clinical trial · NCT07459686
An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
Pfizer·—·not yet recruiting·n = 553
Ulcerative Colitis (UC)Velsipity
brief summary
A study to assess the safety and effectiveness of Velsipity Tablets 2 mg during long-term treatment (up to a maximum of 52 weeks) in patients with ulcerative colitis under actual medical practice.
started
Mar 31, 2026
primary completion
Jan 29, 2029
completion
Jan 29, 2029
last updated
Mar 10, 2026
official title
Velsipity® Tablets 2 mg Special Investigation (Investigation on Long-Term Use in Patients With Ulcerative Colitis)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol